Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats

被引:45
|
作者
Aoi, M [1 ]
Aihara, E [1 ]
Nakashima, M [1 ]
Takeuchi, K [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Kyoto 6078414, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2004年 / 287卷 / 01期
关键词
prostaglandin E-2; EP receptor subtype; EP4; receptor;
D O I
10.1152/ajpgi.00038.2004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We examined, by using a specific PGE receptor subtype EP4 agonist and antagonist, the involvement of EP4 receptors in duodenal HCO3- secretion induced by PGE(2) and mucosal acidification in rats. Mucosal acidification was achieved by exposing a duodenal loop to 10 mM HCl for 10 min, and various EP agonists were given intravenously 10 min before the acidification. Secretion of HCO3- was dose-dependently stimulated by AE1-329 ( EP4 agonist), the maximal response being equivalent to that induced by sulprostone (EP1/EP3 agonist) or PGE(2). The stimulatory action of AE1-329 and PGE(2) but not sulprostone was attenuated by AE3-208, a specific EP4 antagonist. This antagonist also significantly mitigated the acid-induced HCO3- secretion. Coadministration of sulprostone and AE1-329 caused a greater secretory response than either agent alone. IBMX potentiated the stimulatory action of both sulprostone and AE1-329, whereas verapamil mitigated the effect of sulprostone but not AE1-329. Chemical ablation of capsaicin-sensitive afferent neurons did not affect the response to any of the EP agonists used. We conclude that EP4 receptors are involved in the duodenal HCO3- response induced by PGE(2) or acidification in addition to EP3 receptors. The process by which HCO3- is secreted through these receptors differs regarding second-messenger coupling. Stimulation through EP4 receptors is mediated by cAMP, whereas that through EP3 receptors is regulated by both cAMP and Ca2+; yet there is cooperation between the actions mediated by these two receptors. The neuronal reflex pathway is not involved in stimulatory actions of these prostanoids.
引用
收藏
页码:G96 / G103
页数:8
相关论文
共 50 条
  • [11] Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor
    Charo, Chantale
    Holla, Vijaykumar
    Arumugam, Thiruvengadam
    Hwang, Rosa
    Yang, Peiying
    Dubois, Raymond N.
    Menter, David G.
    Logsdon, Craig D.
    Ramachandran, Vijaya
    PANCREAS, 2013, 42 (03) : 467 - 474
  • [12] Prostaglandin E2 EP4 Receptor Activation Attenuates Neuroinflammation and Early Brain Injury Induced by Subarachnoid Hemorrhage in Rats
    Xu, Jie
    Xu, Zhen
    Yan, Ai
    NEUROCHEMICAL RESEARCH, 2017, 42 (04) : 1267 - 1278
  • [13] Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling
    Woodling, Nathaniel S.
    Wang, Qian
    Priyam, Prachi G.
    Larkin, Paul
    Shi, Ju
    Johansson, Jenny U.
    Zagol-Ikapitte, Irene
    Boutaud, Olivier
    Andreasson, Katrin I.
    JOURNAL OF NEUROSCIENCE, 2014, 34 (17) : 5882 - 5894
  • [14] Prostaglandin E2 promotes Staphylococcus aureus infection via EP4 receptor in bovine endometrium
    Liu, Kun
    Mao, Wei
    Liu, Bo
    Li, Tingting
    Wang, Xinfei
    Pei, Le
    Cao, Jinshan
    Wang, Fenglong
    MICROBIAL PATHOGENESIS, 2021, 158
  • [15] Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction
    Bryson, Timothy D.
    Gu, Xiaosong
    Khalil, Remonda M.
    Khan, Safa
    Zhu, Liping
    Xu, Jiang
    Peterson, Edward
    Yang, Xiao-Ping
    Harding, Pamela
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 118 : 1 - 12
  • [16] Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure
    Vukicevic, S.
    Simic, P.
    Borovecki, F.
    Grgurevic, L.
    Rogic, D.
    Orlic, I.
    Grasser, W. A.
    Thompson, D. D.
    Paralkar, V. M.
    KIDNEY INTERNATIONAL, 2006, 70 (06) : 1099 - 1106
  • [17] Prostaglandin E receptor EP4 antagonist suppresses lipopolysaccharide-induced osteoclast formation and inflammatory bone loss
    Matsumoto, Chiho
    Takita, Morichika
    Inada, Masaki
    Maruyama, Takayuki
    Miyaura, Chisato
    JOURNAL OF HEALTH SCIENCE, 2007, 53 (02) : 234 - 239
  • [18] Molecular cloning and characterization of the canine prostaglandin E receptor EP2 subtype
    Hibbs, TA
    Lu, BH
    Smock, SL
    Vestergaard, P
    Pan, LC
    Owen, TA
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1999, 57 (2-3) : 133 - 147
  • [19] Pharmacological characterization of [3H]-prostaglandin E2 binding to the cloned human EP4 prostanoid receptor
    Davis, TL
    Sharif, NA
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) : 1919 - 1926
  • [20] Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro
    Tomita, M
    Li, X
    Okada, Y
    Woodiel, FN
    Young, RN
    Pilbeam, CC
    Raisz, LG
    BONE, 2002, 30 (01) : 159 - 163